Policy
- Manufacturing high-quality medicines in accordance with GMP (Good Manufacturing Practices), GLP (Good Laboratory Practices), and GCP (Good Clinical Practices) standards.
- Reviewing and selecting new medicines to continuously improve the services provided to the medical community.
- Conducting research and promoting innovation to achieve advanced pharmaceutical methods.
- Exploring global markets and exporting the company’s products to various countries.
- Establishing the necessary infrastructure for scientific and industrial cooperation with reputable universities and international pharmaceutical companies.
- Complying with quality management standards (ISO 9001:2008), occupational health and safety management standards (OHSAS 18001:2007), and environmental management standards (ISO 14001:2004).
- Providing continuous training to enhance the scientific and technical knowledge of employees as the company’s most valuable asset.
- Prioritizing consumer rights and encouraging their participation to achieve customer satisfaction and well-being.
- Optimally managing the company’s activities through the implementation of a Management Information System (MIS).
- Optimizing the consumption of resources and energy and reducing waste as an environmentally friendly industry.
Undoubtedly, implementing this policy requires the participation and cooperation of all members of the Raha Pharmaceutical family. The management and employees of the company, relying on Almighty God and through their dedicated efforts, are determined to implement this policy.